Nicholas Short, MD, received his medical degree from the Baylor College of Medicine in Houston, TX. He then completed a residency in internal medicine at the Brigham and Women’s Hospital in Boston, MA, followed by a hematology/oncology fellowship at The University of Texas MD Anderson Cancer Center in Houston, TX.
Dr Short currently serves as an Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. He has been the recipient of numerous awards for his work in leukemia research, including the American Society of Clinical Oncology Young Investigator Award, Leukemia SPORE Career Enhancement Award, K12 Paul Calabresi Career Development Award, and the American Society of Hematology Junior Faculty Scholar Award in Clinical Research.
Dr Short has authored over 100 peer-reviewed articles and numerous abstracts which have been presented at both national and international meetings.
Speaking on MRD detection for acute leukemias
Dr Short is primarily involved in research in the fields of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), as well as in the field of measurable residual disease (MRD) detection for acute leukemias.
Dr Short has been the principal investigator or co-principal investigator on several Phase I and Phase II clinical trials.